Beta-blocker therapy preserves left ventricular ejection fraction in anthracycline-treated breast cancer patients
Beta-blockers May Protect Heart Function in Breast Cancer Patients
This meta-analysis of 772 patients found that beta-blocker therapy significantly preserved left ventricular ejection fraction (LVEF) in pati…
Beta-blockers may help protect heart muscle function in breast cancer patients who receive anthracyclines during their treatment.
Beta-blocker therapy shows no significant reduction in primary composite outcomes for patients with LVEF ≥ 40%
Beta-blocker therapy shows mixed results for heart attack patients
This meta-analysis of 18,504 patients with acute myocardial infarction and LVEF ≥ 40% found no significant reduction in the primary composit…
New data suggests beta-blockers may only show a significant benefit for heart attack patients with specific levels of heart muscle function.
Beta-blocker outcomes vary by myocardial infarction type and left ventricular ejection fraction
Trial shows different heart medication effects based on heart attack type
This prespecified subgroup analysis examined the impact of beta-blockers on primary outcomes in patients with STEMI and NSTEMI. The findings…
New data suggests that beta-blockers may have different impacts on patients depending on the specific type of heart attack they experience.
Proposed evidence-mapping framework addresses diagnostic discordance and pharmacological limitations in sepsis-induced cardiomyopathy
New framework helps doctors manage heart damage from sepsis
This guideline provides a proposed evidence-mapping framework for interpreting bedside diagnostic indices in patients with septic shock and …
New research highlights why current heart tests often fail to show the full extent of damage caused by sepsis.
Impact of Receptor Stimulating Antihypertensive Medications on Alzheimer Disease Risk in Elderly Patients
Certain blood pressure medications may link to lower dementia risk
Retrospective analysis suggests receptor-stimulating antihypertensives may correlate with lower ADRD incidence compared to receptor-inhibiti…
A large study of over 1.5 million seniors suggests specific blood pressure medications may be linked to lower rates of dementia and cognitiv…
Impact of Heart Failure Medications and Ventilation on Duchenne Muscular Dystrophy Survival
Heart medications and ventilation linked to longer life in DMD
A meta-analysis of over 13,000 patients reveals that home mechanical ventilation and heart failure medications significantly extend survival…
New data shows that home ventilation and specific heart medications are linked to longer lifespans for people with Duchenne muscular dystrop…
Beta-blocker therapy shows variable outcomes for myocardial infarction patients based on ejection fraction
Beta-blockers show mixed results for patients with heart conditions
This meta-analysis examined the impact of oral beta-blockers on composite outcomes including death and heart failure in patients following m…
New data shows that beta-blocker medication helps some people after a heart attack, but it may not help everyone equally.
Oral propranolol remains the primary systemic treatment for infantile hemangioma with no superior alternatives
Propranolol Remains the Standard Treatment for Infantile Hemangioma
This meta-analysis of 2639 patients found that no active intervention, including corticosteroids or other beta-blockers, demonstrated statis…
A review of over 2,600 cases shows that while several drugs treat infantile hemangioma, oral propranolol remains a primary standard.
Beta-blocker use associated with lower mortality risk in heart failure with preserved ejection fraction
Beta-Blockers Linked to Lower Mortality in Heart Failure Patients
This meta-analysis of observational studies found that beta-blocker use was associated with lower all-cause and cardiovascular mortality in …
A large study of over 400,000 patients suggests that beta-blocker use is linked to lower death rates for those with a specific type of heart…
ACEIs and Beta Blockers Show Cardioprotective Effects in Chemotherapy
ACE Inhibitors and Beta Blockers May Protect Hearts During Chemotherapy
An umbrella review of 35 meta-analyses finds ACEIs and beta blockers modestly preserve cardiac function and reduce heart failure risk during…
Specific heart medications like ACE inhibitors and beta blockers may help protect heart function in patients undergoing chemotherapy treatme…
Simplified transitional care did not improve guideline adherence in acute heart failure patients over 6 months
Simplified care plan shows no overall benefit for heart failure patients
This multicenter randomized clinical trial enrolled 982 patients with acute heart failure. The study evaluated a simplified transitional car…
A new trial found that a simplified discharge plan did not improve medication adherence or symptoms for most heart failure patients, though …
Saudi Healthcare Workers Show Divergent Knowledge And Attitudes Regarding Beta-Blocker Therapy Management Practices
Doctors and nurses in Saudi Arabia reveal hidden barriers to heart medication
A cross-sectional study of 553 Saudi healthcare providers reveals significant gaps in beta-blocker knowledge and attitudes between physician…
Fear of side effects is stopping doctors and nurses from using a key heart medication the right way, a new survey in Saudi Arabia finds.
All beta-blockers Articles
- Beta-blocker therapy preserves left ventricular ejection fraction in anthracycline-treated breast cancer patients
- Beta-blocker outcomes vary by myocardial infarction type and left ventricular ejection fraction
- Beta-blocker therapy shows no significant reduction in primary composite outcomes for patients with LVEF ≥ 40%
- Proposed evidence-mapping framework addresses diagnostic discordance and pharmacological limitations in sepsis-induced cardiomyopathy
- Impact of Receptor Stimulating Antihypertensive Medications on Alzheimer Disease Risk in Elderly Patients
- Impact of Heart Failure Medications and Ventilation on Duchenne Muscular Dystrophy Survival
- Beta-blocker therapy shows variable outcomes for myocardial infarction patients based on ejection fraction
- Oral propranolol remains the primary systemic treatment for infantile hemangioma with no superior alternatives
- Beta-blocker use associated with lower mortality risk in heart failure with preserved ejection fraction
- ACEIs and Beta Blockers Show Cardioprotective Effects in Chemotherapy
- Simplified transitional care did not improve guideline adherence in acute heart failure patients over 6 months
- Saudi Healthcare Workers Show Divergent Knowledge And Attitudes Regarding Beta-Blocker Therapy Management Practices
- Beta-blocker therapy in AMI patients with preserved ejection fraction shows comparable outcomes to non-use
- Beta-blockers show no mortality benefit in MI patients with preserved ejection fraction
- 24-hour diastolic BP variability linked to renal decline in diabetic kidney disease
- Beta-blockers show no benefit in preserved LVEF post-MI, but may help mildly reduced LVEF
- Meta-analysis finds beta-blockers may reduce cardiotoxicity risk during cancer therapy
- Remote monitoring chatbot increased GDMT target dose achievement in recently discharged HFrEF patients compared to standard care
- Beta-blocker discontinuation noninferior to continuation in stable post-MI patients without heart failure